Aberdeen Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,264
Closed -$1.26M 929
2019
Q1
$1.26M Buy
+31,264
New +$1.26M ﹤0.01% 781